JP2009545527A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009545527A5 JP2009545527A5 JP2009520828A JP2009520828A JP2009545527A5 JP 2009545527 A5 JP2009545527 A5 JP 2009545527A5 JP 2009520828 A JP2009520828 A JP 2009520828A JP 2009520828 A JP2009520828 A JP 2009520828A JP 2009545527 A5 JP2009545527 A5 JP 2009545527A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutically acceptable
- acceptable salt
- formula
- pharmaceutical composition
- compound according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US83186606P | 2006-07-19 | 2006-07-19 | |
| PCT/US2007/016338 WO2008011085A1 (en) | 2006-07-19 | 2007-07-19 | Compositions and methods for the treatment of mucositis |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2009545527A JP2009545527A (ja) | 2009-12-24 |
| JP2009545527A5 true JP2009545527A5 (enExample) | 2010-09-09 |
Family
ID=38617335
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009520828A Pending JP2009545527A (ja) | 2006-07-19 | 2007-07-19 | 粘膜炎の治療用の組成物及び方法 |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US20100035989A1 (enExample) |
| EP (1) | EP2049099A1 (enExample) |
| JP (1) | JP2009545527A (enExample) |
| KR (1) | KR20090040323A (enExample) |
| CN (1) | CN101528218A (enExample) |
| AU (1) | AU2007275658B2 (enExample) |
| BR (1) | BRPI0714562A2 (enExample) |
| CA (1) | CA2658361C (enExample) |
| IL (1) | IL196465A0 (enExample) |
| MX (1) | MX2009000657A (enExample) |
| RU (1) | RU2009101324A (enExample) |
| SG (1) | SG173397A1 (enExample) |
| WO (1) | WO2008011085A1 (enExample) |
| ZA (1) | ZA200900388B (enExample) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL151299A0 (en) | 2000-02-16 | 2003-04-10 | Brigham & Womens Hospital | Aspirin-triggered lipid mediators |
| US8481772B2 (en) * | 2002-04-01 | 2013-07-09 | University Of Southern California | Trihydroxy polyunsaturated eicosanoid derivatives |
| US7902257B2 (en) * | 2002-04-01 | 2011-03-08 | University Of Southern California | Trihydroxy polyunsaturated eicosanoid |
| US20100190735A1 (en) * | 2006-03-28 | 2010-07-29 | Myrex Pharmaceuticals Inc. | Mouthwash and Method of Using Same for the Treatment of Mucositis or Stomatitis |
| EP2679224A1 (en) | 2007-08-01 | 2014-01-01 | University of Pittsburgh of the Commonwealth System of Higher Education | Nitro oleic acid modulation of type II diabetes |
| CN103191129A (zh) * | 2007-10-12 | 2013-07-10 | C.T.辨析有限公司 | 治疗眼睛病症的脂氧化物类化合物 |
| DK2280928T3 (en) | 2008-05-01 | 2018-11-05 | Complexa Inc | Vinyl-substituted fatty acids |
| CN102099024B (zh) | 2008-06-19 | 2015-11-25 | 犹他大学研究基金会 | 硝化脂质在毒性医疗疗法的副作用的治疗上的用途 |
| US20140024713A1 (en) | 2008-06-19 | 2014-01-23 | University Of Utah Research Foundation | Use of nitrated lipids for treatment of side effects of toxic medical therapies |
| US20120122816A1 (en) * | 2009-02-05 | 2012-05-17 | Resolvyx Pharmaceuticals, Inc. | Compositions and methods for organ preservation |
| EP2415748A4 (en) | 2009-02-20 | 2013-08-07 | Univ Tokyo | NEW INFLAMMATORY COMPOUNDS |
| CA2769624C (en) * | 2009-07-31 | 2018-09-11 | University Of Pittsburgh - Of The Commonwealth System Of Higher Education | Electrophilic fatty acid derivatives as anti-inflammatory agents |
| WO2011041639A2 (en) | 2009-10-02 | 2011-04-07 | Miller Raymond A | Heteroatom containing substituted fatty acids |
| EP2744491B1 (en) | 2011-08-19 | 2020-07-29 | The University of Utah Research Foundation | Combination therapy with nitrated lipids and inhibitors of the renin-angiotensin-aldosterone system |
| WO2013116753A1 (en) * | 2012-02-03 | 2013-08-08 | University Of Pittsburgh-Of The Commonwelth System Of Higher Education | Fatty acids as anti-inflammatory agents |
| CN103417471A (zh) * | 2012-05-22 | 2013-12-04 | 吴升华 | 一种治疗湿疹等皮肤炎症的脂氧素乳膏 |
| CA2921845C (en) | 2013-08-19 | 2018-07-10 | Korea Research Institute Of Bioscience And Biotechnology | Compositions containing monoacetyldiacylglycerol compound as an active indredient for preventing or treating rheumatoid arthritis |
| CN106163511A (zh) * | 2014-01-24 | 2016-11-23 | 国立大学法人京都大学 | 含有稀有脂肪酸的抗炎剂 |
| WO2015176012A1 (en) | 2014-05-15 | 2015-11-19 | Enzychem Lifesciences Corporation | Methods for treating leukopenia and thrombocytopenia |
| CA2990521C (en) | 2015-07-07 | 2023-10-10 | H. Lundbeck A/S | Pde9 inhibitors with imidazo triazinone backbone and imidazo pyrazinone backbone for treatment of peripheral diseases |
| CN113440506A (zh) | 2015-10-02 | 2021-09-28 | 康普莱克夏公司 | 使用治疗有效量的活化脂肪酸预防、治疗和逆转疾病 |
| US9808438B2 (en) * | 2015-11-09 | 2017-11-07 | Enzychem Lifesciences Corporation | Method for treating mucositis |
| BR112020024019A2 (pt) | 2018-05-25 | 2021-02-23 | Imara Inc. | monoidrato e formas cristalinas de 6-[(3s,4s)-4-metil-1-(pirimidin-2-ilmetil)pirrolidin-3-il]-3-tetra-hidropiran-4-il-7h-imidazo[1,5-a]pirazin-8-ona |
| KR20250108770A (ko) | 2018-08-31 | 2025-07-15 | 카듀리온 파마슈티칼스, 인크. | 겸상 세포 질환의 치료를 위한 pde9 억제제 |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4576758A (en) * | 1984-06-01 | 1986-03-18 | The Upjohn Company | Anti-inflammatory lipoxin B analogs |
| US6887901B1 (en) * | 1993-06-15 | 2005-05-03 | Brigham & Women's Hospital, Inc. | Lipoxin compounds and their use in treating cell proliferative disorders |
| JP4392473B2 (ja) * | 1999-03-18 | 2010-01-06 | ザ ブライハム アンド ウイメンズ ホスピタル， インコーポレイテッド | ホスホリパーゼｄの活性の調節 |
| IL151299A0 (en) * | 2000-02-16 | 2003-04-10 | Brigham & Womens Hospital | Aspirin-triggered lipid mediators |
| EP1268393A2 (en) * | 2000-03-20 | 2003-01-02 | Trustees Of Boston University | Lipoxin analogs and methods for the treatment of periodontal disease |
| EP1406698B1 (en) * | 2001-03-02 | 2008-10-29 | The Brigham and Women's Hospital | Lipoxin analogs as novel inhibitors of angiogenesis |
| EP1453819A2 (en) * | 2001-12-03 | 2004-09-08 | Novozymes A/S | Statin-like compounds |
| AU2002365167A1 (en) * | 2001-12-18 | 2003-07-09 | The Brigham And Women's Hospital | Inhibition or prevention of infection by bacteria with epa, dha or analogs |
| CA2467580C (en) * | 2001-12-18 | 2012-10-30 | Brigham And Women's Hospital | Use of lipoxin analogs to promote cell defense against gram-negative infections |
| US6949664B2 (en) * | 2002-04-01 | 2005-09-27 | University Of Southern California | Trihydroxy polyunsaturated eicosanoids |
| US7582785B2 (en) * | 2002-04-01 | 2009-09-01 | University Of Southern California | Trihydroxy polyunsaturated eicosanoid derivatives |
| US7378444B2 (en) * | 2002-06-17 | 2008-05-27 | Brigham And Women's Hospital, Inc. | Analogues of lipid mediators derived from omega-3 PUFAs and methods of use |
| DK2216318T3 (en) * | 2002-08-12 | 2018-12-10 | Brigham & Womens Hospital | Resolvins: Bio templates for therapeutic interventions |
| US7759395B2 (en) * | 2002-08-12 | 2010-07-20 | The Brigham And Women's Hospital, Inc. | Use of docosatrienes, resolvins and their stable analogs in the treatment of airway diseases and asthma |
| WO2004110426A1 (en) * | 2003-06-01 | 2004-12-23 | Petasis Nicos A | Modulation of airway inflammation in patients with cystic fibrosis and related diseases |
| US20050203184A1 (en) * | 2003-09-10 | 2005-09-15 | Petasis Nicos A. | Benzo lipoxin analogues |
| CA2588166A1 (en) * | 2004-11-19 | 2006-05-26 | Martek Biosciences Corporation | Oxylipins from long chain polyunsaturated fatty acids and methods of making and using the same |
| US20060293288A1 (en) * | 2005-01-07 | 2006-12-28 | Serhan Charles N | Use of resolvins to treat gastrointestinal diseases |
-
2007
- 2007-07-19 BR BRPI0714562-4A patent/BRPI0714562A2/pt not_active IP Right Cessation
- 2007-07-19 CN CNA2007800344854A patent/CN101528218A/zh active Pending
- 2007-07-19 SG SG2011052230A patent/SG173397A1/en unknown
- 2007-07-19 AU AU2007275658A patent/AU2007275658B2/en not_active Ceased
- 2007-07-19 RU RU2009101324/15A patent/RU2009101324A/ru not_active Application Discontinuation
- 2007-07-19 MX MX2009000657A patent/MX2009000657A/es not_active Application Discontinuation
- 2007-07-19 EP EP07810597A patent/EP2049099A1/en not_active Withdrawn
- 2007-07-19 WO PCT/US2007/016338 patent/WO2008011085A1/en not_active Ceased
- 2007-07-19 KR KR1020097002754A patent/KR20090040323A/ko not_active Ceased
- 2007-07-19 US US12/309,430 patent/US20100035989A1/en not_active Abandoned
- 2007-07-19 JP JP2009520828A patent/JP2009545527A/ja active Pending
- 2007-07-19 CA CA2658361A patent/CA2658361C/en not_active Expired - Fee Related
-
2009
- 2009-01-12 IL IL196465A patent/IL196465A0/en unknown
- 2009-01-16 ZA ZA200900388A patent/ZA200900388B/xx unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2009502793A5 (enExample) | ||
| JP2006515626A5 (enExample) | ||
| JP2007522220A5 (enExample) | ||
| JP2005518413A5 (enExample) | ||
| JP2009535462A5 (enExample) | ||
| JP2007269812A5 (enExample) | ||
| JP2010501534A5 (enExample) | ||
| JP2006526031A5 (enExample) | ||
| JP2012107057A5 (enExample) | ||
| JP2011510079A5 (enExample) | ||
| JP2009149903A5 (enExample) | ||
| JP2010529196A5 (enExample) | ||
| JP2012255026A5 (enExample) | ||
| JP2011527299A5 (enExample) | ||
| ME02558B (me) | Inhibitori replikacije virusa gripa | |
| JP2013518107A5 (enExample) | ||
| JP2010019854A5 (enExample) | ||
| JP2013508347A5 (enExample) | ||
| JP2009524695A5 (enExample) | ||
| JP2009536652A5 (enExample) | ||
| JP2008506632A5 (enExample) | ||
| BRPI0810646A2 (pt) | " compostos farmacêuticos ". | |
| JP2006240292A5 (enExample) | ||
| JP2013509429A5 (enExample) | ||
| IL205071A (en) | Its azulcarboxamide or salt compound, a pharmaceutical product containing it and its uses |